Roswell Park Comprehensive Cancer Center has formed an academic cooperation with the Jagiellonian University in Kraków.
The collaboration will see the two centers exchanging staff, students and scientific resources to undertake basic, translational and clinical research in order to advance the development of cancer therapies.
The agreement grew out of a July 2018 visit by Polish Secretary of State Anna Maria Anders to Roswell Park. Four Roswell Park faculty leaders, joined by Anders, recently traveled to Kraków to initiate the collaboration: Kunle Odunsi, deputy director, chair of gynecologic oncology and executive director of the Center for Immunotherapy; Pawel Kalinski, vice chair for translational research and Rustum Family Professor for Molecular Therapeutics and Translational Research; Agnieszka Witkiewicz, director of the Center for Personalized Medicine and chief for research in the Department of Pathology; and Danuta Kozbor, associate professor of immunology and microbiology.
The agreement is effective immediately, and could see exchange of students and faculty between the two centers as early as spring 2019.
Roswell Park partners with Jagiellonian University in Kraków
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Table of Contents
THE CLINICAL CANCER LETTER
YOU MAY BE INTERESTED IN
More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.
![](https://cdn.cancerletter.com/media/2024/07/12143220/Rejeski-and-Shouval-4x31-1.jpg)
![](https://cdn.cancerletter.com/media/2024/07/12143220/Rejeski-and-Shouval-4x31-1.jpg)
Christy Erickson was seven years old when her mom lost a three-year battle with breast cancer.
![](https://cdn.cancerletter.com/media/2024/07/12143216/Erickson-4x3-1.jpg)
![](https://cdn.cancerletter.com/media/2024/07/12143216/Erickson-4x3-1.jpg)
Two decades after uncovering the role of EGFR mutations in lung cancer, scientists are still grappling with lingering research questions.
![](https://cdn.cancerletter.com/media/2024/07/12143212/Archives-4x3-1.jpg)
![](https://cdn.cancerletter.com/media/2024/07/12143212/Archives-4x3-1.jpg)
Lei Zheng was named executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, and vice president for oncology for the University of Texas Health Science Center at San Antonio.
Mark Burkard was named director of University of Iowa Health Care Holden Comprehensive Cancer Center.